Swiss
Roche should be ‘shamed’ into lowering cancer drug price
September 16, 2014Medical Communications, Sales and Marketing Kadcyla, Margaret Connolly, Roche, Swiss, breast cancer, trastuzumab emtansine
A public petition to force Roche to lower the cost of its costly new breast cancer drug Kadcyla has been …
Oncology drives Roche profits
January 30, 2014Sales and Marketing Actemra, Perjeta, Roche, Swiss, q4
Sales at Roche’s pharma division rose 7% year-on-year in 2013, driven largely by strong performances from its oncology portfolio. Group …
Roche’s Erivedge gains conditional EU approval
July 15, 2013Sales and Marketing Curis, EU, Erivedge, Roche, Swiss, Zelboraf
Roche’s cancer pill Erivedge has received a conditional European approval for treatment of the most common type of skin cancer. …
Acino plant opens to serve Bayer contraceptive patch needs
August 14, 2012Manufacturing and Production Acino, Bayer, R&D, Swiss, contraceptive
Acino has officially opened its new manufacturing facility for transdermal patch products in Miesbach, Germany, which it says makes it …
Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops
July 30, 2012Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss
A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
